DeSilva Malini B, Seburg Elisabeth M, Ehresmann Kirsten, Vazquez-Benitez Gabriela, Daida Yihe G, Vesco Kimberly K, Kharbanda Elyse O, Palmsten Kristin
From the Pregnancy and Child Health Research Center, HealthPartners Institute, Minneapolis, MN.
Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, HI.
Epidemiology. 2025 Mar 1;36(2):160-164. doi: 10.1097/EDE.0000000000001823. Epub 2024 Dec 16.
Electronic health record data are an underused source for lactation-related research. The validity of the International Classification of Diseases, 10th Revision Clinical Modification (ICD-10-CM)-coded lactational mastitis is unknown.
We assessed lactational mastitis diagnosis code validity by medical record review. We included patients from three health care systems with a live birth between December 2020 and September 2022 whose infant had ≥1 well visit and for whom there was electronic health record documentation of lactation in patient or infant records. We used ICD-10-CM diagnosis codes (N61.0 and O91.2) to identify patients with suspected lactational mastitis and assessed antibiotic dispensings. We performed medical record reviews on a random sample to determine whether suspected lactational mastitis cases met definitions for "probable" (breast symptoms with systemic symptoms) or "possible" (breast symptoms without systemic symptoms) lactational mastitis. We report positive predictive values (PPV) with 95% confidence intervals (CI).
Among 19,660 eligible patients, 1,023 (5.2%) had either N61.0 or O91.2 diagnosis code and 768 (3.9%) had a diagnosis code and antibiotic dispensed. Chart reviews of 119 identified PPV of 76% (95% CI: 67.3, 82.9) for probable and 97% (95% CI: 91.6, 98.7) for probable or possible lactational mastitis. Restricting to those dispensed an antibiotic (n = 87), PPVs improved to 80% (95% CI: 69.6, 87.4) for probable and 100% (95% CI: 95.8, 100) for probable or possible lactational mastitis.
Diagnosis codes alone have good PPV for lactational mastitis. PPV for lactational mastitis improves when including antibiotic data, although case numbers decrease. Future research may consider the use of ICD-10 codes alone for the identification of lactational mastitis.
电子健康记录数据是泌乳相关研究中未得到充分利用的资源。国际疾病分类第十次修订临床修订本(ICD - 10 - CM)编码的哺乳期乳腺炎的有效性尚不清楚。
我们通过病历审查评估哺乳期乳腺炎诊断代码的有效性。我们纳入了来自三个医疗保健系统的患者,这些患者在2020年12月至2022年9月期间有活产,其婴儿有≥1次健康检查,并且在患者或婴儿记录中有哺乳期的电子健康记录文档。我们使用ICD - 10 - CM诊断代码(N61.0和O91.2)来识别疑似哺乳期乳腺炎的患者并评估抗生素配药情况。我们对随机样本进行病历审查,以确定疑似哺乳期乳腺炎病例是否符合“可能”(伴有全身症状的乳房症状)或“可能”(无全身症状的乳房症状)哺乳期乳腺炎的定义。我们报告阳性预测值(PPV)及其95%置信区间(CI)。
在19660名符合条件的患者中,1023名(5.2%)有N61.0或O91.2诊断代码,768名(3.9%)有诊断代码且配了抗生素。对119份病历的审查发现,“可能”哺乳期乳腺炎的PPV为76%(95%CI:67.3,82.9),“可能或可能”哺乳期乳腺炎的PPV为97%(95%CI:91.6,98.7)。将范围限制在那些配了抗生素的患者(n = 87),“可能”哺乳期乳腺炎的PPV提高到80%(95%CI:69.6,87.4),“可能或可能”哺乳期乳腺炎的PPV提高到100%(95%CI:95.8,100)。
仅诊断代码对哺乳期乳腺炎有良好的PPV。纳入抗生素数据时,哺乳期乳腺炎的PPV会提高,尽管病例数会减少。未来的研究可能会考虑单独使用ICD - 10代码来识别哺乳期乳腺炎。